Table 3.

Model-predicted odds ratios for potential CVD risk factors among patients with hemophilia

EffectOdds ratio95% confidence intervalP
Age ≥ 65 y vs age < 65 y 1.18 0.40-3.48 .761 
White vs non-white 0.19 0.05-0.75 .018 
Ever smoker vs no smoker 3.12 1.20-8.11 .020 
Positive family history of CVD vs no family history 1.89 0.76-4.73 .172 
HTN vs no HTN 5.07 1.27-20.21 .022 
Dyslipidemia vs no dyslipidemia 3.87 1.07-13.96 .039 
DM vs no DM 1.20 0.42-3.39 .734 
Hemophilia A vs B 0.44 0.16-1.17 .100 
HIV vs no HIV 1.49 0.41-5.41 .548 
Inhibitor vs no inhibitor 9.18 1.26-66.90 .029 
Severe vs moderate hemophilia with HCV 0.81 0.19-3.37 .879 
Severe vs moderate hemophilia without HCV 0.23 0.06-0.99 .049 
EffectOdds ratio95% confidence intervalP
Age ≥ 65 y vs age < 65 y 1.18 0.40-3.48 .761 
White vs non-white 0.19 0.05-0.75 .018 
Ever smoker vs no smoker 3.12 1.20-8.11 .020 
Positive family history of CVD vs no family history 1.89 0.76-4.73 .172 
HTN vs no HTN 5.07 1.27-20.21 .022 
Dyslipidemia vs no dyslipidemia 3.87 1.07-13.96 .039 
DM vs no DM 1.20 0.42-3.39 .734 
Hemophilia A vs B 0.44 0.16-1.17 .100 
HIV vs no HIV 1.49 0.41-5.41 .548 
Inhibitor vs no inhibitor 9.18 1.26-66.90 .029 
Severe vs moderate hemophilia with HCV 0.81 0.19-3.37 .879 
Severe vs moderate hemophilia without HCV 0.23 0.06-0.99 .049 

CVD, cardiovascular disease; DM, diabetes mellitus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; HTN, hypertension.

or Create an Account

Close Modal
Close Modal